(Q37866814)

24 August 2017

1 reference

title

Post-exposure prophylaxis for HIV infection (English)

1 reference

post-exposure prophylaxis

24 August 2017

main subject

1 reference

David Rey

1

1 reference

24 August 2017

publication date

1 April 2011

1 reference

Expert Review of Anti-infective Therapy

24 August 2017

published in

1 reference

24 August 2017

volume

9

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

431-442

1 reference

Estimation of HIV incidence in the United States

24 August 2017

cites work

1 reference

A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group

21 January 2018

1 reference

Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2).

21 January 2018

1 reference

Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells

21 January 2018

1 reference

Post-exposure prophylaxis for SIV revisited: animal model for HIV prevention

21 January 2018

1 reference

Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection

21 January 2018

1 reference

Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial

21 January 2018

1 reference

A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers

21 January 2018

1 reference

Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus

21 January 2018

1 reference

Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV.

21 January 2018

1 reference

Transmission of drug-resistant HIV after an occupational exposure despite postexposure prophylaxis with a combination drug regimen

21 January 2018

1 reference

Seroconversion following nonoccupational postexposure prophylaxis against HIV.

21 January 2018

1 reference

Failure of postexposure prophylaxis after sexual exposure to HIV.

21 January 2018

1 reference

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

21 January 2018

1 reference

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

21 January 2018

1 reference

Sexual risk behaviors among heterosexual HIV serodiscordant couples in the era of post-exposure prevention and viral suppressive therapy

21 January 2018

1 reference

Use of non-occupational post-exposure prophylaxis does not lead to an increase in high risk sex behaviors in men who have sex with men participating in the EXPLORE trial

21 January 2018

1 reference

Nonoccupational postexposure prophylaxis, subsequent risk behaviour and HIV incidence in a cohort of Australian homosexual men.

21 January 2018

1 reference

Two drugs or three? Balancing efficacy, toxicity, and resistance in postexposure prophylaxis for occupational exposure to HIV.

21 January 2018

1 reference

Effect of menses on clearance of Y-chromosome in vaginal fluid: implications for a biomarker of recent sexual activity.

21 January 2018

1 reference

Nonoccupational HIV post-exposure prophylaxis: a 10-year retrospective analysis

21 January 2018

1 reference

Tolerability of postexposure prophylaxis with the combination of zidovudine-lamivudine and lopinavir-ritonavir for HIV infection

21 January 2018

1 reference

Tolerability of two different combinations of antiretroviral drugs including tenofovir used in occupational and nonoccupational postexposure prophylaxis for HIV.

21 January 2018

1 reference

Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals

21 January 2018

1 reference

Hepatotoxicity associated with long- versus short-course HIV-prophylactic nevirapine use: a systematic review and meta-analysis from the Research on Adverse Drug events And Reports (RADAR) project.

21 January 2018

1 reference

Tolerance of a short course of nevirapine, associated with 2 nucleoside analogues, in postexposure prophylaxis of HIV.

21 January 2018

1 reference

Raltegravir for postexposure prophylaxis following occupational exposure to HIV.

21 January 2018

1 reference

Expanded postexposure prophylaxis for simultaneous multiple source HIV exposure in a health-care worker

21 January 2018

1 reference

Post-exposure prophylaxis with a maraviroc-containing regimen after occupational exposure to a multi-resistant HIV-infected source person

21 January 2018

1 reference

Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus

21 January 2018

1 reference

Cost-effectiveness of HIV postexposure prophylaxis following sexual or injection drug exposure in 96 metropolitan areas in the United States

21 January 2018

1 reference

Cost-effectiveness of HIV post-exposure prophylaxis in France

21 January 2018

1 reference

Sexual transmission of HIV-1.

21 January 2018

1 reference

Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use.

21 January 2018

1 reference

Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART

21 January 2018

1 reference

Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial

21 January 2018

1 reference

Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial

21 January 2018

1 reference

Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial

21 January 2018

1 reference

Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed

21 January 2018

1 reference

Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis.

21 January 2018

1 reference

Severe ototoxicity in a health care worker who received postexposure prophylaxis with stavudine, lamivudine, and nevirapine after occupational exposure to HIV.

21 January 2018

1 reference

Clinical practice. Postexposure prophylaxis for HIV infection

21 January 2018

1 reference

Evaluating counseling outcome on adherence to prophylaxis and follow-up after sexual HIV-risk exposure: a randomized controlled trial

21 January 2018

1 reference

Postexposure prophylaxis for victims of sexual assault: treatments and attitudes of emergency department physicians

21 January 2018

1 reference

Impact of telephonic psycho-social support on adherence to post-exposure prophylaxis (PEP) after rape

21 January 2018

1 reference

Occupational risks and hepatitis B vaccination status of dental auxiliaries in Nigeria

21 January 2018

1 reference

Management of accidental exposure to blood in the Treichville teaching hospital, Abidjan (Côte-d'Ivoire)

21 January 2018

1 reference

The structure and outcomes of a HIV postexposure prophylaxis program in a high HIV prevalence setup in western Kenya

21 January 2018

1 reference

Delivering post-rape care services: Kenya's experience in developing integrated services

21 January 2018

1 reference

[Antiretroviral prophylaxis after non-occupational exposure to HIV in Abidjan (Cote d'Ivoire)].

21 January 2018

1 reference

Postexposure prophylaxis in children and adolescents for nonoccupational exposure to human immunodeficiency virus

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERI.11.20

1 reference

24 August 2017

1 reference